AKT1 and glioblastoma: Aside from its effects on the activation of the Akt/mTOR pathway (97), the partial or complete PTEN deficiency potentially induces the secretion of Gal-9 (99), as it does in glioblastoma cells via the AKT-GSK-3β-IRF1 pathway.